{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:35:01Z","timestamp":1791329701018,"version":"4.3.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.spen.2008.03.004","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T16:17:25Z","timestamp":1213373845000},"page":"79-90","source":"Crossref","is-referenced-by-count":60,"title":["Pediatric Sleep Pharmacology"],"prefix":"10.1016","volume":"15","author":[{"given":"Rafael","family":"Pelayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2008.03.004_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/000992280604500304","article-title":"Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance","volume":"45","author":"Schnoes","year":"2006","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.spen.2008.03.004_bib2","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1542\/peds.111.5.e628","article-title":"Medication use in the treatment of pediatric insomnia: Results of a survey of community-based pediatricians","volume":"111","author":"Owens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2008.03.004_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/sleep\/30.8.1013","article-title":"Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings","volume":"30","author":"Stojanovski","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0031-3955(03)00179-2","article-title":"Pediatric sleep pharmacology: You want to give my kid sleeping pills?","volume":"51","author":"Pelayo","year":"2004","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.spen.2008.03.004_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2008.03.004_bib6","series-title":"International Classification of Sleep Disorders","year":"2005"},{"key":"10.1016\/j.spen.2008.03.004_bib7","first-page":"1277","article-title":"Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib8","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/sleep\/29.11.1415","article-title":"Practice parameters for the psychological and behavioral treatment of insomnia: An update","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/sleep\/27.6.1195","article-title":"Delayed sleep phase syndrome: Pathophysiology and treatment options","volume":"27","author":"Wyatt","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/sleep\/22.5.641","article-title":"Practice parameters for the use of light therapy in the treatment of sleep disorders","volume":"22","author":"Chesson","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archpsyc.63.10.1149","article-title":"Ramelteon: A novel hypnotic lacking abuse liability and sedative adverse effects","volume":"63","author":"Johnson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/cap.2006.16.631","article-title":"Ramelteon for insomnia in two youths with autistic disorder","volume":"16","author":"Stigler","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2008.03.004_bib13","series-title":"Goodman and Gilman's the Pharmacologic Basis of Therapeutics","year":"1996"},{"key":"10.1016\/j.spen.2008.03.004_bib14","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1067\/mai.2000.106153","article-title":"The effects of antihistamines on cognition and performance","volume":"105","author":"Kay","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.spen.2008.03.004_bib15","first-page":"245","article-title":"Case 1 presentation of bizarre behaviors","volume":"19","author":"Duke","year":"1998","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.spen.2008.03.004_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/j.1552-4604.1976.tb02406.x","article-title":"The effectiveness of diphenhydramine HCI in pediatric sleep disorders","volume":"16","author":"Russo","year":"1976","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.spen.2008.03.004_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1520\/JFS2002121","article-title":"Fatal diphenhydramine intoxication in infants","volume":"48","author":"Baker","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.spen.2008.03.004_bib18","first-page":"72555","article-title":"Labeling of diphenhydramine-containing drug products for over-the-counter human use","volume":"67","year":"2002","journal-title":"Fed Regist"},{"key":"10.1016\/j.spen.2008.03.004_bib19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1067\/mpd.2001.112647","article-title":"Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine","volume":"138","author":"Bender","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib20","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1476-5381.1995.tb16386.x","article-title":"Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography","volume":"116","author":"Yanai","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.spen.2008.03.004_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(02)02276-2","article-title":"Roles of histamine in regulation of arousal and cognition: Functional neuroimaging of histamine H1 receptors in human brain","volume":"72","author":"Tashiro","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.spen.2008.03.004_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1989.3","article-title":"The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance","volume":"45","author":"Gengo","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.spen.2008.03.004_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01067905","article-title":"Pharmacokinetics of diphenhydramine in man","volume":"3","author":"Albert","year":"1975","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.spen.2008.03.004_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archpedi.160.7.707","article-title":"The trial of infant response to diphenhydramine: The TIRED study\u2014A randomized, controlled, patient-oriented trial","volume":"160","author":"Merenstein","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.spen.2008.03.004_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3476(98)70240-9","article-title":"Risk of abuse of diphenhydramine in children and adolescents with chronic illnesses","volume":"133","author":"Dinndorf","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib26","first-page":"1999","article-title":"Sleep: Notes on pediatric pharmacotherapy (in the light of current knowledge of its principal characteristics)","volume":"27","author":"Nigro","year":"1975","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00006565-199912000-00018","article-title":"Chloral hydrate: The good and the bad","volume":"15","author":"Pershad","year":"1999","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.spen.2008.03.004_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/1086508X.2006.11079593","article-title":"Sleep\/sedation in children undergoing EEG testing: a comparison of chloral hydrate and music therapy","volume":"46","author":"Loewy","year":"2006","journal-title":"Am J Electroneurodiagnostic Technol"},{"key":"10.1016\/j.spen.2008.03.004_bib29","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/archotol.127.12.1510","article-title":"Are second-generation antihistamines appropriate for most children and adults?","volume":"127","author":"Haydon","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.spen.2008.03.004_bib30","first-page":"625","article-title":"Comparative safety of H1 antihistamines","volume":"67","author":"Meltzer","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1016\/j.spen.2008.03.004_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/014556130007900908","article-title":"Nasal congestion: A review of its etiology, evaluation, and treatment","volume":"79","author":"Corey","year":"2000","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.spen.2008.03.004_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0531-5565(01)00120-6","article-title":"Human aging and melatonin","volume":"36","author":"Touitou","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.spen.2008.03.004_bib33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1345\/aph.17111","article-title":"Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia","volume":"32","author":"Wagner","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.spen.2008.03.004_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.38731.532766.F6","article-title":"Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis","volume":"332","author":"Buscemi","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.spen.2008.03.004_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/088307380101600215","article-title":"Melatonin replacement therapy in a child with a pineal tumor","volume":"16","author":"Jan","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2008.03.004_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/088307380101600204","article-title":"Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial","volume":"16","author":"Smits","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2008.03.004_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01","article-title":"Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia","volume":"45","author":"Weiss","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.chi.0000246055.76167.0d","article-title":"Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia","volume":"46","author":"Van der Heijden","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00787-005-0424-4","article-title":"The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders\u2014A case series","volume":"14","author":"Ingrassia","year":"2005","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines","volume":"48","author":"Ashton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.spen.2008.03.004_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00023210-200216120-00002","article-title":"Parasomnias: Epidemiology and management","volume":"16","author":"Wills","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.spen.2008.03.004_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2165\/00003088-199529030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of zolpidem","volume":"29","author":"Salva","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.spen.2008.03.004_bib43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0149-2918(00)83024-6","article-title":"Zaleplon: A pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia","volume":"22","author":"Weitzel","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.spen.2008.03.004_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5664\/jcsm.26657","article-title":"Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening","volume":"2","author":"Zammit","year":"2006","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.spen.2008.03.004_bib45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.clpt.6100380","article-title":"Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties","volume":"83","author":"Blumer","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.spen.2008.03.004_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clinthera.2006.04.014","article-title":"Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia","volume":"28","author":"Najib","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.spen.2008.03.004_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.sleep.2005.06.004","article-title":"An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia","volume":"6","author":"Roth","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.spen.2008.03.004_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/sleep\/30.8.959","article-title":"Nightly treatment of primary insomnia with eszopiclone for six months: Effect on sleep, quality of life, and work limitations","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00148581-200002010-00001","article-title":"Narcolepsy in children: A practical guide to its diagnosis, treatment and follow-up","volume":"2","author":"Guilleminault","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.spen.2008.03.004_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.spen.2008.03.004_bib51","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2008.03.004_bib52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2008.03.004_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/sleep\/24.5.603","article-title":"Practice parameters for the treatment of narcolepsy: An update for 2000","volume":"24","author":"Littner","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib54","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib55","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/sleep\/30.12.1712","article-title":"Treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Wise","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002018-200225110-00004","article-title":"Benefits and risks of pharmacotherapy for narcolepsy","volume":"25","author":"Mitler","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.spen.2008.03.004_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/phgs.4.1.23.22590","article-title":"Pharmacogenomics in the treatment of narcolepsy","volume":"4","author":"Tafti","year":"2003","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.spen.2008.03.004_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pnpbp.2007.07.025","article-title":"Modafinil as a treatment for Attention-Deficit\/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial","volume":"32","author":"Amiri","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib59","first-page":"352","article-title":"Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit\/hyperactivity disorder: Pooled analysis of 3 randomized, double-blind, placebo-controlled studies","volume":"8","author":"Wigal","year":"2006","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4088\/JCP.v67n0120","article-title":"Modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: Results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation","volume":"67","author":"Swanson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.spen.2008.03.004_bib61","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1542\/peds.2005-0617","article-title":"Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: Results of a randomized, double-blind, placebo-controlled, flexible-dose study","volume":"116","author":"Biederman","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2008.03.004_bib62","first-page":"31","article-title":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy","volume":"26","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1592\/phco.22.9.798.34063","article-title":"Sodium oxybate (GHB) for treatment of cataplexy","volume":"22","author":"Borgen","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.spen.2008.03.004_bib64","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00023210-200721040-00007","article-title":"Sodium oxybate: A review of ts use in the management of narcolepsy","volume":"21","author":"Robinson","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.spen.2008.03.004_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002018-200427050-00002","article-title":"The Xyrem risk management program","volume":"27","author":"Fuller","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.spen.2008.03.004_bib67","first-page":"24","article-title":"Date-rape drug approved for cataplexy","volume":"32","author":"Xyrem","year":"2002","journal-title":"Nursing"},{"key":"10.1016\/j.spen.2008.03.004_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","article-title":"Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients","volume":"21","author":"Scharf","year":"1998","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","author":"Mignot","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.spen.2008.03.004_bib70","first-page":"1079","article-title":"Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy","volume":"264","author":"Nishino","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.spen.2008.03.004_bib71","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1164\/ajrccm.152.4.7551385","article-title":"Supplemental oxygen during sleep in children with sleep-disordered breathing","volume":"152","author":"Marcus","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.spen.2008.03.004_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1164\/ajrccm.164.1.2008171","article-title":"Sleep-disordered breathing in children","volume":"164","author":"Marcus","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.spen.2008.03.004_bib73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3476(95)70262-8","article-title":"Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea","volume":"127","author":"Marcus","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib74","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/ajrccm.158.3.9802019","article-title":"Pharmacologic treatment of sleep-disordered breathing","volume":"158","author":"Hudgel","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.spen.2008.03.004_bib75","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0278-2391(96)90170-6","article-title":"Nonsurgical management of the obstructive sleep apnea patient","volume":"54","author":"Thornton","year":"1996","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.spen.2008.03.004_bib76","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mpd.2001.114474","article-title":"Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea","volume":"138","author":"Brouillette","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib77","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1067\/mpd.2001.116063","article-title":"Nasal steroids as treatment for obstructive sleep apnea: Don't throw away the scalpel yet","volume":"138","author":"Marcus","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2008.03.004_bib78","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.2005-0795","article-title":"Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children","volume":"117","author":"Kheirandish","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2008.03.004_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2006-2767","article-title":"Restless legs syndrome: Prevalence and impact in children and adolescents\u2014The Peds REST study","volume":"120","author":"Picchietti","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2008.03.004_bib80","doi-asserted-by":"crossref","unstructured":"Picchietti DL, Stevens HE: Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2007 [Epub ahead of print]","DOI":"10.1016\/j.sleep.2007.08.012"},{"key":"10.1016\/j.spen.2008.03.004_bib81","doi-asserted-by":"crossref","unstructured":"Mohri I, Kato-Nishimura K, Tachibana N, et al: Restless legs syndrome (RLS): An unrecognized cause for bedtime problems and insomnia in children. Sleep Med 2007 [Epub ahead of print]","DOI":"10.1016\/S1389-9457(07)70343-X"},{"key":"10.1016\/j.spen.2008.03.004_bib82","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/1531-8257(199911)14:6<1000::AID-MDS1014>3.0.CO;2-P","article-title":"Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder","volume":"14","author":"Picchietti","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2008.03.004_bib83","first-page":"970","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder","volume":"22","author":"Hening","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.sleep.2007.06.007","article-title":"Is iron deficiency an underlying cause of pediatric restless legs syndrome and of attention-deficit\/hyperactivity disorder?","volume":"8","author":"Picchietti","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.spen.2008.03.004_bib85","first-page":"101","article-title":"Restless legs syndrome: Pathophysiology and the role of iron and folate","volume":"12","author":"Patrick","year":"2007","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.spen.2008.03.004_bib86","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.sleep.2007.04.022","article-title":"Impact of restless legs syndrome and iron deficiency on attention-deficit\/hyperactivity disorder in children","volume":"8","author":"Konofal","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.spen.2008.03.004_bib87","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pediatrneurol.2006.11.004","article-title":"Children with autism: Effect of iron supplementation on sleep and ferritin","volume":"36","author":"Dosman","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2008.03.004_bib88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.sleep.2003.12.002","article-title":"Iron status and periodic limb movements of sleep in children: A causal relationship?","volume":"5","author":"Beard","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.spen.2008.03.004_bib89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/sleep\/26.6.735","article-title":"Periodic limb movements in sleep and iron status in children","volume":"26","author":"Simakajornboon","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2008.03.004_bib91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/sleep\/27.3.557","article-title":"Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder","volume":"27","author":"Littner","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib92","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/sleep\/22.7.961","article-title":"Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder","volume":"22","author":"Chesson","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0887-8994(99)00152-6","article-title":"Dopaminergic therapy in children with restless legs\/periodic limb movements in sleep and ADHD","volume":"22","author":"Walters","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2008.03.004_bib94","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/sleep\/19.10.801","article-title":"Pergolide and carbidopa\/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients","volume":"19","author":"Earley","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.spen.2008.03.004_bib96","series-title":"Gellis and Kagan\u2018s Current Pediatric Therapy","author":"Burg","year":"2002"},{"key":"10.1016\/j.spen.2008.03.004_bib97","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00002826-198706000-00004","article-title":"Clinical presentation and neuropharmacology of restless legs syndrome","volume":"10","author":"Walters","year":"1987","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.spen.2008.03.004_bib98","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.43.2.445","article-title":"Dopaminergic treatment of restless legs and rebound phenomenon","volume":"43","author":"Guilleminault","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2008.03.004_bib99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004691-200103000-00004","article-title":"Restless legs syndrome: A review of clinical and pathophysiologic features","volume":"18","author":"Allen","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.spen.2008.03.004_bib100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO;2-F","article-title":"CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome","volume":"16","author":"Earley","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2008.03.004_bib101","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2008.03.004_bib102","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.59.4.639","article-title":"Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome","volume":"59","author":"Allen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2008.03.004_bib103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2008.03.004_bib104","doi-asserted-by":"crossref","unstructured":"Allen RP, Ritchie SY. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset. Sleep Med 2007 [Eput ahead of print]","DOI":"10.1016\/j.sleep.2007.08.017"},{"key":"10.1016\/j.spen.2008.03.004_bib105","doi-asserted-by":"crossref","unstructured":"Quilici S, Abrams KR, Nicolas A, et al: Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med 2008 [Epub ahead of print]","DOI":"10.1016\/j.sleep.2007.11.020"},{"key":"10.1016\/j.spen.2008.03.004_bib106","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: A double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909108000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909108000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T09:47:16Z","timestamp":1588758436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909108000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1071909108000284"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2008.03.004","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}